Funded Tech Companies
NephroDI Therapeutics
Wondering who backed NephroDI Therapeutics? Xontogeny joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
NephroDI Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1606 Chestnut St. 3
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff Sands and Janet Klein, recognized clinical and research leaders in kidney diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/13/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachael Hagan
Founder
Ish Khanna
Founder
Janet Klein
Founder
Ram Pillarisetti
Founder
Jeffrey Sands
Company Investors
- Xontogeny (Chris Garabedian)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs